Purpose: Volumetric modulated arc therapy ͑VMAT͒ is a specific type of intensity-modulated radiation therapy ͑IMRT͒ in which the gantry speed, multileaf collimator ͑MLC͒ leaf position, and dose rate vary continuously during delivery. A treatment planning system for VMAT is presented. Methods: Arc control points are created uniformly throughout one or more arcs. An iterative least-squares algorithm is used to generate a fluence profile at every control point. The control points are then grouped and all of the control points in a given group are used to approximate the fluence profiles. A direct-aperture optimization is then used to improve the solution, taking into account the allowed range of leaf motion of the MLC. Dose is calculated using a fast convolution algorithm and the motion between control points is approximated by 100 interpolated dose calculation points. The method has been applied to five cases, consisting of lung, rectum, prostate and seminal vesicles, prostate and pelvic lymph nodes, and head and neck. The resulting plans have been compared with segmental ͑step-and-shoot͒ IMRT and delivered and verified on an Elekta Synergy to ensure practicality. Results: For the lung, prostate and seminal vesicles, and rectum cases, VMAT provides a plan of similar quality to segmental IMRT but with faster delivery by up to a factor of 4. For the prostate and pelvic nodes and head-and-neck cases, the critical structure doses are reduced with VMAT, both of these cases having a longer delivery time than IMRT. The plans in general verify successfully, although the agreement between planned and measured doses is not very close for the more complex cases, particularly the head-and-neck case. Conclusions: Depending upon the emphasis in the treatment planning, VMAT provides treatment plans which are higher in quality and/or faster to deliver than IMRT. The scheme described has been successfully introduced into clinical use.
I. INTRODUCTION
Intensity-modulated arc therapy ͑IMAT͒ as proposed by Yu 1 has been used for several years to treat patients in a short treatment time using high-quality dose distributions. 2, 3 This technique makes various gantry arcs with dynamic multileaf collimation to build up fluence modulation. A related technique using a single gantry arc and rather more vigorous leaf motion has also been proposed by Crooks et al. 4 The possibilities of IMAT have given rise to several planning algorithms 5, 6 and related theoretical concepts. [7] [8] [9] However, all of these methods involve the delivery of dose with constant dose rate. Recently, linear accelerators have become available which are able to vary gantry speed, multileaf collimator ͑MLC͒ leaf position, and dose rate simultaneously, a technique known as volumetric modulated arc therapy ͑VMAT͒.
Treatment planning for VMAT is challenging due to the requirement to sequence the MLC leaves in such a way that the leaf motion is minimal and within the allowed maximum leaf speed of the linear accelerator. Furthermore, the beam weights should be such that the dose rate of the accelerator is not required to drop to a value lower than the accelerator can reliably deliver. Several schemes have been proposed, [10] [11] [12] [13] [14] [15] [16] and various planning studies have been conducted to determine how VMAT compares in dosimetric quality to segmental intensity-modulated radiation therapy ͑IMRT͒ and tomotherapy. [17] [18] [19] [20] [21] [22] [23] However, there are still some open questions. 24 This paper therefore describes a treatment planning scheme for VMAT with particular emphasis on providing deliverable plans which can be executed and verified with confidence. General methods are described, but the scheme is illustrated with reference to the Elekta Synergy ͑Crawley, U.K.͒ accelerator. This implementation of VMAT has variable gantry speed, variable collimator angle, variable collimator position, variable MLC leaf position, and variable dose rate. A number of control points are prescribed to the accelerator, each defining the gantry angle, the collimator angle, the position of the collimators, the position of the MLC leaves, and the cumulative monitor units delivered at a particular instance in the treatment delivery. The delivery control system then moves the gantry, collimators, and MLC leaves dynamically between the positions specified at the control points, while the dose rate is chosen so that at each control point, the correct cumulative monitor units have been delivered. A feedback system repeatedly monitors the actual accelerator conditions and adjusts the motion and dose rate to ensure that the prescription is accurately followed. The planning algorithm is described with reference to this paradigm and then illustrated using a variety of clinical cases of varying complexity. In particular, three novel features are presented: ͑a͒ An accurate means of handling clinical objectives and constraints in an iterative least-squares optimization of fluence, which allows this fast but seldom used optimization method to be used for the many beam orientations which are encountered in VMAT, ͑b͒ a control point grouping and sequencing scheme for VMAT, and ͑c͒ an efficient method of calculating dose for the dynamic aperture motion in VMAT.
II. METHODS

II.A. Background
The VMAT planning algorithm has been implemented in the AUTOBEAM ͑v4.9͒ in-house software developed at the Royal Marsden and described previously. [25] [26] [27] CT scans and outlines are read from PINNACLE 3 ͑Philips Radiation Oncology Systems, Madison, WI͒ and inverse planning is then performed in a separate software. The inverse planning algorithm consists of three stages: Fluence optimization, segmentation, and direct-aperture optimization.
II.B. Arc definition
The algorithm begins with the definition of arcs. The arcs are defined by uniformly distributing the desired number of control points throughout the specified range of gantry, couch, and collimator angles. There can be any number of arcs, noncoplanar if desired. At this point, having defined the control points, it is possible to proceed immediately to direct-aperture optimization to determine the optimum aperture shapes and monitor units for the control points. However, this is very inefficient, so we use the well-established three-step process of fluence optimization, segmentation, and then direct-aperture optimization, the latter being used for fine-tuning. The concept of a control point group is introduced with this in view. A single control point cannot, on its own, deliver intensity-modulated radiation to the patient: A number of control points are required to be collected together so that, working together, albeit at slightly different gantry or collimator angles, they deliver a modulated fluence profile to the patient. The control point group provides this collection of control points. Beginning with the first control point of the first beam, a set of control point groups is defined whose gantry, couch, and collimator angles differ by less than or equal to a specified tolerance ͑Fig. 1͒. For example, if there are two arcs with 5°spacing of control points, one a clockwise arc starting at 190°and ending at 170°and the other an anticlockwise arc starting at 170°and ending at 190°͑a typical arrangement͒, and the tolerance angle is 10°, the control points at 190°, 195°, and 200°in each of the two beams, a total of six control points, form the first segment group, and so on. From these six control points, an optimal fluence map can be reproduced with deliverable aperture shapes. Note that although the above illustration uses two arcs, this algorithm is general and can be used for any number of arcs.
By setting the tolerance angle for the control point grouping, the user can therefore specify how the control points are to be used. Compared to segmental delivery, a large tolerance angle corresponds to few static beams with many segments per beam and a small tolerance angle corresponds to many static beams with few segments per beam.
II.C. Fluence optimization
In principle, one fluence profile is required to be determined for each control point group. At the segmentation stage, the control points of the group are then set to represent the fluence profile. The fluence profile could be determined for the gantry angle at the center of the gantry angle range represented by the control point group ͑e.g., Ref. 16͒. However, this is not optimal, since the control points of the group are at different gantry angles, and the positions of the organs at risk in the beam's eye view vary with gantry angle. Creating a single fluence profile at a single gantry angle, segmenting this fluence profile, and then distributing the segments to other gantry angles in the control point group results in beam apertures which do not properly match the organs at risk. An alternative strategy is therefore used. A fluence profile is generated for each discrete beam orientation, as defined by gantry, couch, and collimator angles, for which there is a control point. ͑Collimator angle is included here as rotation of the collimator implies rotation of the corresponding fluence map, which requires explicit reoptimization of fluence.͒ Thus, the example in Fig. 1 would have three fluence profiles per control point group. Consequently, when the segmentation step is reached, each control point is associated with a fluence profile which belongs properly to its own gantry, couch, and collimator angles. ͑See Sec. II D below for details of exactly how the segmentation proceeds.͒ Fluence is optimized using the iterative least-squares algorithm as originally implemented in image reconstruction and applied to radiation therapy by Xing and Chen. 28 The method iterates through the pixels of the fluence map, comparing the dose actually delivered by each pencil beam of radiation and the prescribed dose and correcting the fluence accordingly. Let the fluence delivered by the jth element of the entire set of fluence profiles around the patient be denoted by w j and the dose delivered to voxel i of the patient by unit fluence element j be denoted by d ij . If the prescribed dose at voxel i of the patient is denoted by d i p and the corresponding actual dose is d i = ͚ j d ij w j , then the correction applied to w j at each iteration is
where R = 0.001 is a relaxation parameter included to promote divergence and ␣ i is the importance factor associated with each individual voxel. The presence of the first d ij in the numerator is to weight the correction according to the contribution that a fluence element makes to each voxel in the patient. In other words, deviations from the prescribed dose at voxels which receive a high dose from w j influence the correction more than deviations at voxels which receive a low dose from w j : There is no point in making a large change to a fluence element because of a large deviation from the prescribed dose at a particular voxel if that fluence element does not contribute significantly to that voxel. The denominator is a normalization factor. So far, the method follows that of Xing and Chen. 28 However, the method 28 has the same limitation as all of the inverse planning algorithms which rely on a prescribed dose distribution, which is that the prescribed dose is not actually known. Rather, a series of dose, dose-volume, and biological constraints is available, and the prescribed dose can be anything appropriate to these limits. Hence, the method is used in an adapted form, in which d i p is simply equal to the prescribed dose for target structures and zero elsewhere. The importance factors ␣ i are then used to control the algorithm by evaluating an objective function. The objective function is constructed from treatment plan statistics, which can be ͑a͒ root-mean-square dose deviation from a specified dose level, used for controlling PTV dose inhomogeneity, ͑b͒ minimum dose, ͑c͒ maximum dose, ͑d͒ mean dose, ͑e͒ irradiated volume, ͑f͒ dose to the hottest fraction of a structure, ͑g͒ tumor control probability, or ͑h͒ normal tissue complication probability. These quantities can be maximized or minimized but for simplicity, minimization is considered here. The treatment plan statistics are represented as f 1 ͑d i ͒ , f 2 ͑d i ͒ , f 3 ͑d i ͒ ,... in the form of M objectives and N constraints. The objectives relate to volumes of interest V m ͑m =1, ... , M͒ and the constraints relate to volumes of interest V n ͑n =1, ... ,N͒, with multiple objectives and constraints allowed for each volume, so that some of the V m and V n are the same volume. In addition, the volumes may overlap in space. Each objective and constraint implies a corresponding spatial importance factor:
where ␤ m are user-defined importance factors, c n are limits on the N constraints, and A is a large constant importance factor. 27 H is the Heaviside unit step function. Then:
This is used in Eq. ͑1͒. The effect is that if the dose to a structure is far from the dose-volume constraint, for example, the importance factor is large, giving emphasis to that structure in the optimization. Once a constraint is met, the objective function for that structure becomes zero, and the importance factor consequently zero as well. Overall, the algorithm proceeds by calculating ⌬w j for all j, then implementing the corrected w j , giving the new improved dose distribution, calculating the new set of spatial importance factors ␣ i , then repeating the process for 100 iterations. At the completion of the fluence optimization, the fluence profiles are lightly filtered using a cosine-shaped low-pass filter to remove any unrealistic high-frequency components which cannot be sensibly segmented.
II.D. Segmentation
Segmentation is achieved by stratification of the fluence profiles. The individual fluence profile for each control point in the group is divided into as many intensity levels as there are control points in the group, the first level being specified by the user and the remainder being equally spaced in intensity. Over the range of angles in the group, the fluence profiles are very similar due to the iterative least-squares algorithm used for the fluence optimization but vary slightly due to the difference in angle over the width of the segment group. The first control point in the group is then set to deliver the first level of its intensity map, the second segment is then set to deliver the second level of its own respective intensity map, and so on ͑Fig. 2͒. This is approximately equivalent to segmenting one single fluence profile, except that each control point aperture aligns itself with the fluence profile intended for its own particular gantry, couch, and collimator angles. However, it is not an exact process due to the changes in the fluence profiles between beam angles. For example, the segment marked with an asterisk in Fig. 2 is not delivered by any of the control points. This is because at the gantry angle of control points 3 and 4, a second peak in the fluence profile has arisen, so that control point 4 addresses the second peak rather than the main peak. Effects such as this are not dealt with at this stage as they can be corrected for by the direct-aperture optimization later on.
The aperture shape at each level in the intensity map is selected by bracketing the leftmost ͑in an arbitrary sense͒ peak in the fluence profile to rise above the specified intensity level. Computationally, this is achieved as follows. If there are s apertures to be identified, the first segment having weight a and the remainder having weight b, then a + ͑s −1͒b = 1 for a single-peaked fluence map with unit maximum intensity. The segmentation proceeds by drawing all pixels of the fluence map which are nonzero to a binary bitmap, setting to zero the rightmost pixels in any rows of the bitmap having multiple disconnected islands ͑so that the leftmost islands remain͒, then finding the boundary of the bitmap. This defines an aperture shape, and the weight of this segment is then subtracted from the overall fluence map as it has been accounted for. This process is repeated until all of the s segments have been identified. If there are multiple peaks in the bitmap, some of the fluence map is still unaccounted for because only the leftmost peaks have been bracketed. Thus, the weights of the s segments are all increased by a factor ͑s +1͒ / s and the whole process is repeated until the s segments account for the entire fluence map.
Once the segmentation is completed, the allowed range of leaf motion is enforced by moving each leaf to a position suitably close to its position at the previous control point. This enforcement of allowed range of leaf motion is governed by the user's intention for the treatment delivery. There is actually no limit on the allowable range of leaf positions in the delivery because if the required leaf motion is too great to move the leaf at maximum gantry speed and dose rate, the accelerator lowers the gantry speed and dose rate so that the leaf motion can be achieved within the permissible maximum speed. However, this may not be the user's intention. For example, for a lung treatment with Active breathing coordinator ͑Elekta, Crawley, U.K.͒, it is important to complete the treatment in the minimum length of time so as to minimize the number of breath holds that the patient is required to perform. The user therefore supplies the minimum gantry speed for the delivery. From this, the maximum leaf motion between segments is simply calculated.
II.E. Direct-aperture optimization
At the end of the segmentation stage, the aperture shapes and segment weights are set as if the plan is to be delivered segmentally ͑i.e., with step-and-shoot delivery͒. This is due to the nature of the segmentation algorithm and can be seen clearly from Fig. 2 . However, during dynamic delivery, the dose is deposited between control points, so that the first control point has zero weight by definition, and the weights of the subsequent control points refer to the monitor units delivered between the previous control point and the present one. At the start of the direct-aperture optimization, the weight of the first control point in each arc is therefore set to zero. From this point onwards, the dose calculation also takes into account the motion of the aperture shapes between control points. Both of these changes cause a temporary re- duction in plan quality, but the optimization subsequently corrects for this perturbation.
The direct-aperture optimization phase takes the deliverable but suboptimal plan produced by the segmentation step and improves it for delivery. The optimization is a constrained optimization, with the collimator positions and the positions of several key MLC leaves being optimized and the remaining MLC leaves being fitted by a polynomial function, so as to ensure rational aperture shapes. There are also constraints on minimum leaf gap, minimum aperture width and length, and minimum equivalent square. The method uses a multidimensional downhill search, relying on the initial segmentation to ensure that it begins in the approximate region of the global minimum of the objective function. The downhill search cycles through the collimators and MLC leaves to be optimized, selects each in turn, and systematically finds the optimum leaf position of the selected leaf, before moving on to the next leaf. The allowed range of leaf positions is taken into account when systematically searching through the leaf/jaw positions. Segment weights are also optimized during this process. Ten complete cycles through all of the variables are completed, as the optimum value of one variable depends upon the current values of the other variables. This method has been shown to converge to the minimum of an optimization space, so long as there are no local minima. 29 In this case, there are local minima, but the initial segmentation is used to ensure that the optimization starts in the vicinity of the global minimum.
Using the notation introduced above in Sec. II C, the objective function is
where B is a small constant importance factor. Since this has a similar form to Eqs. ͑2͒ and ͑3͒, the direct-aperture optimization proceeds in a similar direction in parameter space to the fluence optimization. The remaining details of the optimization are very similar to those published previously 26, 27 and so are not repeated here.
II.F. Dose calculation
Dose calculations are performed using a fast convolution algorithm with inhomogeneity correction. 30 The method can therefore be used for lung planning and other dosimetrically challenging sites. In order to accurately model the motion of the apertures between the control points, 100 linear interpolations of the apertures are made between control points and dose is summed over these interpolated apertures. To clarify the explanation, we refer to control points as the actual states supplied to the accelerator and segments as static beams with a specific orientation, aperture shape, and weight, used for computation purposes only. Let the P control points be indexed by p ͑p =1, ... , P͒ and let the pth control point have beam orientation A p , aperture shape S p , and segment weight w p . The weight of the first control point has been set to zero and remains zero, i.e., w 0 = 0. For each of control points 2, ... , P, 100 interpolated segments are created, each having orientation A pq , aperture shape S pq , and weight w pq ͑q =1, ... ,100͒, such that
In principle, dose is now calculated for each of these interpolated segments to model the motion of the aperture between control points. However, this would in practice require a prohibitively long time. We therefore make the approximation A pq = A p , p = 2, ... ,P, q = 1, . . . ,100. ͑9͒
So long as the P control points are reasonably closely spaced, this is sufficiently accurate in practice. The value of this is that we now have only P − 1 segment orientations to calculate, as opposed to 100ϫ ͑P −1͒ orientations. Each control point now has 100 segments, all at that orientation. Figure 3 illustrates the situation. The form of the dose calculation is as follows. 30 Let the beam space be spanned by a coordinate system whose x and y axes are orthogonal to the beam axis and whose z axis is parallel to the beam axis and let the equivalent square field size of aperture S pq be s pq . Then the total energy released per unit mass ͑TERMA͒ is characterized by an output factor f pq ͑s pq ͒, an incident fluence profile r pq ͑x , y , S pq ͒, and a depth component t pq ͑z , s pq ͒. The TERMA is convolved with a convolution kernel k p ͑x , y , z͒, which is the same for all segments at a given orientation. The dose due to each set of 100 segments, all at the same orientation, can be calculated as Hence, the complete calculation for all 100 interpolated segments can be achieved by a straightforward two-dimensional summation of the individual aperture shapes into an effective fluence, followed by the same ray tracing and convolution as a single segment. Overall, the calculation of dose for an arc with P control points takes a similar time to the calculation of dose for P − 1 simple static beams. The complete inverse planning process, including fluence optimization, segmentation, and direct-aperture optimization, takes around 3-24 h depending upon the complexity of the plan, running in JAVA on a single core of a 2.4 GHz AMD Opteron processor in a Sun Ultra 40 M2 workstation ͑Sun Microsystems, Santa Clara, CA͒. Further work is in progress to optimize the speed of execution and to introduce multithreaded operation so as to reduce this time. At present, several plans can be calculated simultaneously on different processor cores, so the long calculation time is not clinically prohibitive. Also, the nature of the direct-aperture optimization is that it can be terminated early if a good quality solution has been obtained before the ͑generous͒ normal number of iterations has been completed. The final plan is exported from AUTOBEAM to the accelerator ͑or record and verify system͒ in DICOM format. The plan is delivered dynamically, with gantry speed, collimator position, MLC leaf position, and dose rate varying between control points. In addition, a PINNACLE 3 script is written which can then be run within PINNACLE 3 to set up the plan for visualization purposes as pseudoarcs consisting of static beams. Similarly to the process described above, each control point is represented as a step-and-shoot beam of ten segments. The ten segments are equally weighted and contain linear interpolations of the apertures at the control points. Only ten interpolations are used at this stage for purposes of practicality. This approach allows the well-established PINNACLE 3 collapsed cone convolution dose calculation to be used for the final dose calculation. Note, however, that no modification can be made to the plan in PINNACLE 3 as the prescription is sent to the accelerator directly from AUTO-BEAM. In summary, the true VMAT prescription is sent directly from AUTOBEAM to the accelerator, while the static approximation is sent from AUTOBEAM to PINNACLE 3 for visualization purposes only. The software has been introduced into clinical use. 
II.G. Planning study
Five cases were retrospectively planned with this scheme as illustrations of the performance for plans of varying complexity ͑Table I͒. The VMAT plans were compared against segmental ͑step-and-shoot͒ treatment plans. In order to ensure consistency in the planning comparison, AUTOBEAM was also used for the segmental plans, so that the same objectives, constraints, and segment size limitations could be applied. The cases were ͑a͒ a lung case, intended to be simple and fast as a precursor to hypofractionated stereotactic body irradiation, ͑b͒ a treatment of prostate and seminal vesicles according to the CHHIP trial, consisting of three target volumes, ͑c͒ a rectal tumor, consisting of two treatment vol- umes, the main volume containing the primary tumor, locoregional lymph nodes plus a 1.5 cm margin, and a boost volume consisting of the primary tumor alone plus a 1.5 cm margin, ͑d͒ prostate and pelvic lymph nodes, giving an example of a more challenging concave target volume, and ͑e͒ a head-and-neck case, consisting of primary and nodal volumes, which was the most complex of the plans considered. The emphasis in the choice of inverse planning parameters for these cases was from fast delivery ͑a͒ to high-quality dose distribution ͑e͒. The nominal gantry speed and the number of arcs were the two main factors in influencing this emphasis ͑see Table I͒ . All cases were delivered on Elekta Synergy linear accelerators ͑Elekta Ltd., Crawley, U.K.͒ running RTDESKTOP v7.01. The accelerators were fully commissioned for VMAT delivery. 32 The lung case and the prostate and seminal vesicles case were planned for, and delivered using, a unit with a Beam Modulator head. This had 4 mm leaf width at the isocenter, fixed jaws, and interdigitation. The remaining cases were planned for, and delivered using, an MLCi head, which had 10 mm leaf width at the isocenter, variable jaws, and no interdigitation. The segmental IMRT plans were delivered at a dose rate of 600 MU/min. The delivery times, from the start of the first beam to the end of the last beam, were recorded for both the VMAT plans and the corresponding segmental IMRT plans. A DELTA 4 phantom ͑Scandidos, Uppsala, Sweden͒ was also used to verify the dose distributions calculated in PINNACLE 3 . 33 The percentage of the points of measurement agreeing to within 3% of the dose to the primary PTV and 3 mm was recorded for all of the plans. Detectors recording less than 20% of the dose to the primary PTV were excluded from the gamma analysis. The plans were assessed against the departmental acceptance criterion that 90% of points of measurement should agree with the plan to within 3% and 3 mm.
III. RESULTS
Typical control point beam's eye views as seen in AUTO-BEAM are shown in Fig. 4 for the prostate and seminal vesicles ͑Beam Modulator͒ and prostate and pelvic nodes ͑MLCi͒ cases. The type of MLC ͑i.e., with or without interdigitation, fixed or moving collimators͒ influences the shape of the segments considerably. Transaxial, sagittal, and coronal dose distributions are shown in Fig. 5 for the VMAT plans for all five clinical cases. It can be seen that VMAT produces very conformal plans with well-controlled dose distributions. Dose-volume histograms comparing VMAT with segmental IMRT for all cases are shown in Fig. 6 . For the lung case, prostate and seminal vesicles, and rectum cases, there is generally ͑with a few exceptions͒ a small improvement in target coverage and a small reduction in critical structure dose. For the prostate and pelvic nodes and headand-neck cases, VMAT gives considerably reduced critical structure doses compared to IMRT. The irradiated volume of normal tissue is generally higher with VMAT, with the exception of the head-and-neck case ͑Table II͒.
The total monitor units and delivery times are given in Table III . For the simpler cases, the monitor units with VMAT are similar to those for IMRT, and the delivery times are rather shorter. For the more complex cases, where the emphasis is on plan quality rather than delivery speed, more monitor units are required with VMAT than for IMRT and the delivery time is longer.
The VMAT plan for the prostate and pelvic nodes case is shown in Fig. 7 as it appears in the DELTA 4 software. Similar results are obtained for both the IMRT and VMAT plans for all of the cases. The percentage of measurements agreeing with the plan to within 3% and 3 mm drops gradually as the cases become more complex ͑Table III͒. Assessed against the criterion that 90% of the measurements should agree with the plan to within 3% and 3 mm, all of the verification results are acceptable for both VMAT and IMRT plans, with the exception of the head-and-neck VMAT case.
IV. DISCUSSION
This paper takes the previous scheme of IMRT with constrained aperture shapes and applies it to planning for VMAT. The concept of simple apertures is very suited to VMAT because with VMAT, the apertures smoothly vary with time. Complex "flag-pole" segments where leaves are positioned behind the opposing jaw so as to overcome constraints in collimator position are not sensible in VMAT because the aperture shapes produced as the leaves move smoothly toward and away from this position are unusual and likely to give poor dosimetric agreement with the treatment planning system. In order to improve the agreement of the delivered plan with the treatment planning system, the inverse planning has been designed to include modeling of the leaf motion. For simple cases, where the leaves do not move much between segments, this may not be necessary: It may be sufficient to sum the contributions of the apertures at the control points only. However, for complex cases where the leaves move several centimeters between control points, some form of modeling is necessary to correctly predict the delivered dose. A classic example of this is for apertures irradiating either side of the spinal cord in a head-and-neck case. In a segmental treatment plan, one aperture may irradiate one side of the cord and another aperture may irradiate the other side of the cord. The same two apertures, if used as two adjacent control points in a VMAT plan, will give rise to a distribution of dose across the cord as the leaves move from one side of the cord to the other. However, if the motion of the leaves is not modeled, the treatment planning system will predict nearperfect sparing of the cord, because only the apertures at the control points, i.e., either side of the cord, are taken into account. It is for this reason that leaf motion modeling has been included in the inverse planning scheme.
The cases have been chosen to show the range of possible modulation complexities, from a single-arc lung plan with fairly conformal apertures to a three-arc head-and-neck plan with apertures which differ very much from the conformal beam's eye view of the PTV. VMAT can be used for conformal arcs as well as for complex aperture shapes, the three basic accelerator capabilities used in VMAT, variation of gantry speed, leaf position, and dose rate, being used to provide a well-balanced conformal plan. As well as choosing an appropriate degree of modulation for the case to be treated, it is also sensible to choose the arcs to suit the target arrangement. A single arc may have benefits in terms of delivery efficiency, but multiple arcs are necessary for accurate delivery of complex plans. The present algorithm can deal with both of these situations. For example, the lung and prostate and seminal vesicles cases can be accurately planned and delivered with a single arc, whereas in the rectum case, a clockwise arc with nonconformal aperture shape ranging over the full extent of the phase 1 volume, followed by an anticlockwise conformal arc directed to the phase 2 volume, works well. The prostate and pelvic nodes and head-andneck cases require several modulated arcs for reliable planning and delivery. As a general rule, it has been found that cases with multiple target volumes requiring multiple prescription doses are best dealt with using several arcs, one directed to each of the target volumes. Hence, the head-andneck case has been planned using an arc to the high-dose volume plus an arc to each of the nodal PTVs.
The main factor influencing the complexity of the modulation is the nominal gantry speed. If the inverse planning is performed with the gantry intended to move at maximum speed, only limited motion of the collimators and MLC leaves is allowed. Conversely, if considerable motion of the collimators and MLC leaves is allowed at the planning stage, a more exquisite treatment plan will result but the delivery time will be much longer. The parameters used for planning the cases in this paper have been chosen to illustrate the complete range of plan quality and delivery speed. Other choices are possible: For example, the prostate and pelvic nodes and head-and-neck cases could have been planned for improved speed compared to segmental delivery. In this case, the plan quality would not be so high, but the delivery would be faster.
The complexity of the plan also influences the verification results. If the nominal gantry speed is high, there is less collimator and MLC leaf motion, which means that the dose calculation model with interpolated collimator and MLC leaf positions is more accurate. It is also easier for the accelerator to deliver the plan as the delivery speeds are more uniform. Finally, the dose measurement device, in this case the DELTA 4 , has itself a finite uncertainty in measurement. It is thought that all of these factors contribute to the failure of the head-and-neck case to satisfy the gamma criterion. This case has 51 control points per arc, which equates to 7°con-trol point spacing, which is fairly large, together with a low nominal gantry speed, giving rise to considerable motion between these control points, and these factors combine to create a challenge for the dose calculation to model the dynamic delivery. The motion between the control points is also challenging for the accelerator to deliver smoothly. Improving the accuracy of planning and delivery for such cases is the subject of an ongoing study.
The improved speed of delivery with VMAT for the simple cases should lead to an overall improvement in efficiency of treatment. VMAT lends itself naturally to simultaneous cone-beam imaging and treatment due to the gantry rotation. For imaging schedules where cone-beam scans are acquired on the first days of treatment, followed by a shift, these initial scans could be obtained simultaneously with the VMAT delivery, 34 leading to a short treatment time. This would be beneficial for the departmental workflow and would also lead to improved accuracy of delivery and a more favorable experience for the patient.
V. CONCLUSIONS
An inverse planning scheme for VMAT, using constrained aperture shapes and modeling of MLC leaf motion between control points, has been developed and clinically implemented. Comparison studies show that this inverse planning scheme used in conjunction with an Elekta accelerator produces treatments which are slightly improved in efficacy to segmental IMRT, with a treatment time which is up to four times faster. In the cases with multiple prescription doses, the fraction size is given for the planning target volume with the highest dose.
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FIG. 7. DELTA 4 results for the VMAT prostate and pelvic nodes plan. The planned dose distribution is shown in grayscale and with isodoses, the measured dose is shown in colored points, and the histograms of dose difference, distance to agreement, and gamma ͑3% and 3 mm͒ are shown from left to right below.
